Medicare Enrolled
Dr. Andres Mesa, M.D.
Cardiovascular Disease · Houston, TX
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mesa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mesa?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mesa
Dr. Andres Mesa is a cardiovascular disease specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mesa performed 1,498 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mesa received a total of $104,157 from 52 pharmaceutical and/or device companies across 794 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mesa is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 1,498 Medicare services
$104,157 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,498
Medicare services
Bottom 37% in TX for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$123
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
399 | $89 | $377 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
367 | $10 | $52 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
176 | $39 | $256 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
124 | $137 | $1,235 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
77 | $30 | $250 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
66 | $51 | $350 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
43 | $116 | $512 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
28 | $1,936 | $3,500 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 28 | $651 | $830 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
27 | $146 | $200 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
26 | $94 | $157 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
25 | $340 | $1,435 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
25 | $49 | $247 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
24 | $677 | $2,815 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
23 | $153 | $620 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
21 | $20 | $80 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
19 | $55 | $750 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
8.3% high complexity
24.2% medium
67.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$104,157
Total received (2018-2024)
Avg $14,880/year across 7 years
Top 6% in TX for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
794
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,975
2023
$5,039
2022
$7,915
2021
$2,354
2020
$13,695
2019
$66,776
2018
$4,403
Payments by company (2024)
Boston Scientific Corporation
$1,598
Medtronic, Inc.
$478
E.R. Squibb & Sons, L.L.C.
$302
Novartis Pharmaceuticals Corporation
$238
Abbott Laboratories
$237
AstraZeneca Pharmaceuticals LP
$237
ASAHI INTECC USA, INC.
$91
Novo Nordisk Inc
$84
Esperion Therapeutics, Inc.
$83
Merck Sharp & Dohme LLC
$81
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$76
Boehringer Ingelheim Pharmaceuticals, Inc.
$69
HEARTFLOW, INC.
$64
Lexicon Pharmaceuticals, Inc.
$60
Baxter Healthcare
$39
Cleerly, Inc.
$37
Amgen Inc.
$34
Janssen Pharmaceuticals, Inc
$33
Janssen Biotech, Inc.
$26
SANOFI-AVENTIS U.S. LLC
$24
Bard Peripheral Vascular, Inc.
$23
AGEPHA Pharma FZ LLC
$17
iRhythm Technologies, Inc.
$16
Kiniksa Pharmaceuticals International, plc
$15
CashFlow Solutions, LLC
$14
Top 3 companies account for 59.8% of 2024 payments
All-time payments by company (2018-2024) ›
Amarin Pharma Inc.
$74,121
Bard Peripheral Vascular, Inc.
$6,291
Boston Scientific Corporation
$5,444
Medtronic, Inc.
$4,150
Cardiovascular Systems Inc.
$1,893
Abbott Laboratories
$1,682
Medtronic Vascular, Inc.
$1,632
Novartis Pharmaceuticals Corporation
$1,004
Janssen Pharmaceuticals, Inc
$930
AstraZeneca Pharmaceuticals LP
$820
E.R. Squibb & Sons, L.L.C.
$723
BOSTON SCIENTIFIC CORPORATION
$643
Boehringer Ingelheim Pharmaceuticals, Inc.
$528
Amgen Inc.
$442
Merck Sharp & Dohme LLC
$392
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$346
Tactile Systems Technology Inc
$343
Venclose Inc.
$305
Novo Nordisk Inc
$295
SANOFI-AVENTIS U.S. LLC
$274
Esperion Therapeutics, Inc.
$232
PFIZER INC.
$210
Preventice Services, LLC
$205
Impulse Dynamics (USA) Inc.
$145
ASAHI INTECC USA, INC.
$91
Lexicon Pharmaceuticals, Inc.
$78
AngioDynamics, Inc.
$66
HEARTFLOW, INC.
$64
iRhythm Technologies, Inc.
$62
ARALEZ PHARMACEUTICALS US INC.
$59
Baxter Healthcare
$58
Bayer HealthCare Pharmaceuticals Inc.
$53
Chiesi USA, Inc.
$52
CHIESI USA, INC.
$51
Merck Sharp & Dohme Corporation
$42
CashFlow Solutions, LLC
$41
NormaTec Industries, LP
$41
Kiniksa Pharmaceuticals, Ltd.
$40
Cleerly, Inc.
$37
Saranas, Inc.
$31
Surmodics, Inc.
$27
Janssen Biotech, Inc.
$26
Lilly USA, LLC
$24
EISAI INC.
$23
GE HEALTHCARE
$21
CVRx, Inc.
$20
Endologix, LLC
$19
Daiichi Sankyo Inc.
$18
AGEPHA Pharma FZ LLC
$17
G Medical Diagnostic Services, Inc.
$16
Avinger Inc.
$15
Kiniksa Pharmaceuticals International, plc
$15
Top 3 companies account for 82.4% of all-time payments
Associated products mentioned in payments ›
AFX · ALPHAVAC · Advisa · Arcalyst · Assurity Pacemaker · BG Mini Plus · BRILINTA · Barostim Neo System · BodyGuardian · CAMZYOS · CARDIOMEMS · CHANTIX · COREVALVE EVOLUT R · Cardiac Monitoring Suite · CareLink · Cleerly Ischemia · ClosureFast · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · Diamondback Peripheral · ELIQUIS · EMBLEM · EMBLEM MRI S-ICD · ENTRESTO · ERLEADA · EVRSF · FARXIGA · FFRct · FLEXITOUCH · GENERAL TACHY · GENERAL - VASCULAR ACCESS · GENERAL BRADY · GENERAL PAIN MANAGEMENT · HEARTMATE TOUCH · HawkOne · HeartMate 3 Left Ventricular Dev · HeartMate Touch · HeartWare HVAD · Hillrom - Carnation Ambulatory Monitor · IN.PACT Admiral · INJECTAFER · Inpefa · JARDIANCE · KENGREAL · KENGREAL 50MG/10ML L · LATITUDE · LATITUDE Communicator Power Supply · LEQVIO · LODOCO · LUMAKRAS · LUTONIX · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LYMPHA PRESS OPTIMAL PLUS(US) BT · Lenvima · LifeVest · Lympha Press Optimal Plus(US) BT · MICRA · MULTAQ · Merlin Connectivity and Remote · MitraClip System · Model 4625 ACUITY X4 Connector Tool · NEXLETOL · Omnilink Elite vascular stent system · Optimizer Smart System · Optis Coronary Imaging System · Ozempic · PANTHERIS · PERIPHERAL VASCULAR · PRADAXA · PRALUENT · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · Pounce Thrombectomy System · QUADRA ASSURA · RESONATE · RESONATE EL ICD VR · RETEVMO · Repatha · Reveal LINQ · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VENASEAL · VERQUVO · VIGILANT · VIGILANT X4 CRT-D · VYNDAQEL · Vascepa · VenaSeal · Venclose · Venclose Maven Catheter · Verquvo · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · XIENCE SKYPOINT · Xience V coronary stent system · ZIO Patch · ZIO XT Patch · ZONTIVITY · Zio monitor · myLUX Patient Kit with mobile device
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
335
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
AD HOSPITAL EAST, LLC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mesa is a cardiac & electrophysiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mesa experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mesa performed 399 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mesa receive payments from pharmaceutical companies?
Yes. Dr. Mesa received a total of $104,157 from 52 companies across 794 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mesa's costs compare to other cardiologists in Houston?
Dr. Mesa's average Medicare payment per service is $123. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mesa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Houston
Browse cardiologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc.
By company
Bard Peripheral Vascular, Inc. Payments to Doctors
See all physicians who received payments from Bard Peripheral Vascular, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology